Trial Profile
A Phase II Trial of Pemetrexed (ALIMTA, LY231514, IND #40061) as Salvage Therapy for Failed Low Risk Gestational Trophoblastic Tumor
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 04 Nov 2021
Price :
$35
*
At a glance
- Drugs Pemetrexed (Primary)
- Indications Trophoblastic tumour
- Focus Adverse reactions; Therapeutic Use
- 19 Apr 2018 New trial record